|
|||||
|
|
Phase I Dose‐Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors |
|
| Authors: | Junning Cao Dongmei Ji Zhiyu Chen Weina Shen Jin Wang Baoyue Li Haidong Chi Amanda Long Ling Gao Jin Li |
| Affiliation: | 1. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China;2. Lilly China Drug Development and Medical Affairs Center, Shanghai, People's Republic of China;3. Global Pharmacokinetics/Pharmacodynamics, Eli Lilly and Company, Indianapolis, Indiana, USA;4. Global Pharmacokinetics/Pharmacodynamics, Eli Lilly and Company, Bridgewater, Massachusetts, USA |
| Abstract: | |
| Keywords: | |